Afuco™ Anti-Human BDKRB2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-BDKRB2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-BKB2R antibodies having the variable region sequences are useful for altering one or more of BKB2R of and/or GSK-3 signaling pathways for the treatment of diseases, disorders and conditions such as cancer, diabetes, cardiovascular disorders and other conditions.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-062CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | BDKRB2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |